Other studies have also shown the possible pro‐inflammatory role of MMP‐9 in nonplacental malaria and some have suggested the potential use of MMP‐9 inhibitors as drugs for nonplacental malaria, particularly for complicated malaria (Dietmann et al., 2008; Polimeni & Prato, 2014; Prato & Giribaldi, 2011; Van den Steen et al., 2006). This evidence concerns the gene MMP9 and malaria.